| Balance sheet (USD) | FY 2025 ended Dec 31, 2025 | FY 2024 ended Dec 31, 2024 | FY 2023 ended Dec 31, 2023 | FY 2022 ended Dec 31, 2022 | FY 2021 ended Dec 31, 2021 | FY 2020 ended Dec 31, 2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 14.56B | 13.24B | 6.84B | 12.69B | 8.10B | 8.05B |
| Short-term investments | 0 | 447.00M | 252.00M | 498.00M | 0 | 0 |
| Receivables | 11.78B | 10.28B | 10.35B | 9.45B | 9.23B | 6.80B |
| Inventory | 6.66B | 6.11B | 6.36B | 5.91B | 5.95B | 5.55B |
| Total current assets | 43.52B | 38.78B | 32.17B | 35.72B | 30.27B | 27.76B |
| Property, plant and equipment | 25.32B | 23.78B | 23.05B | 21.42B | 19.28B | 17.00B |
| Goodwill and intangibles | 48.26B | 38.04B | 39.21B | 41.47B | 44.20B | 32.98B |
| Total assets | 136.87B | 117.11B | 106.67B | 109.16B | 105.69B | 91.59B |
| Accounts payable | 4.40B | 4.08B | 3.92B | 4.26B | 4.61B | 4.33B |
| Total current liabilities | 28.33B | 28.42B | 25.69B | 24.24B | 23.87B | 27.33B |
| Long-term debt | 46.75B | 34.46B | 33.68B | 28.75B | 30.69B | 25.36B |
| Total liabilities | 84.26B | 70.79B | 69.09B | 63.17B | 67.51B | 66.27B |
| Retained earnings | 73.08B | 63.07B | 53.90B | 61.08B | 53.70B | 47.36B |
| Shareholders' equity | 52.61B | 46.31B | 37.58B | 45.99B | 38.18B | 25.32B |
| Total debt | 49.34B | 37.11B | 35.05B | 30.69B | 33.10B | 31.79B |
| Net debt | 34.77B | 23.87B | 28.21B | 18.00B | 25.01B | 23.74B |
From Merck's 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read balance sheet or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.